SAN DIEGO, Sept. 27, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in for certain investors in ReWalk Robotics Ltd (NASDAQ:RWLK) over alleged Securities Laws violations by ReWalk Robotics Ltd in connection the company’s September 12, 2014 initial public offering.
Investors who purchased shares of ReWalk Robotics Ltd (NASDAQ:RWLK) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of the investors, who purchased ReWalk Robotics Ltd (NASDAQ:RWLK) common shares pursuant or traceable to its initial public offering ("IPO") on September 12, 2014, that the defendants violated the Securities Act of 1933.
The plaintiff claims that the company’s registration statement for its September 12, 2014 IPO contained untrue statements of material facts, omitted to state other facts necessary to make the statements made not misleading and/or was not prepared in accordance with the rules and regulations governing its preparation.
More specifically, the plaintiff alleges that the company’s registration statement for its September 12, 2014 IPO failed to disclose that despite the regulatory requirements to comply with “special controls” and provide the FDA with a postmarket surveillance study of ReWalk Robotics ReWalk product, the company was woefully unprepared and/or unable to do so.
The plaintiff claims that at a minimum, ReWalk Robotics Ltd should have disclosed in the registration statement for its September 12, 2014 IPO that its own internal clinical and regulatory resources were then insufficient to enable the company to comply with the FDA’s postmarket surveillance requirements and that the registration statement should have disclosed that to cure this deficiency, it was incumbent on the Company to hire or contract for a larger number of skilled employees to enable ReWalk Robotics Ltd to plan, undertake, and timely complete an adequate postmarket surveillance study that would satisfy FDA standards.
Shares of ReWalk Robotics Ltd (NASDAQ:RWLK) declined from as high as $43.71 per share on September 15, 2014 to as low as $5.55 per share on December 11, 2015.
Those who purchased ReWalk Robotics Ltd (NASDAQ:RWLK) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108


Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
First Western Ship Transits Strait of Hormuz Since Iran War Began
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Apple Turns 50: From Garage Startup to AI Crossroads
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 



